View in EDS

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults ≥50 years of age: A randomized trial.

Saved in:

Bibliographic Details
Title:	Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults ≥50 years of age: A randomized trial.
Authors:	Maréchal, Céline¹, Lal, Himal², Heineman, Thomas C², Poder, Airi³, Ferguson, Murdo⁴, Enweonye, Igwebuike⁵, Hervé, Caroline⁶, Wauters, Dominique⁶, Oostvogels, Lidia⁶, Rheault, Paul⁷, Talli, Jaak⁸
Source:	Vaccine. Jul2018, Vol. 36 Issue 29, p4278-4286. 9p.
Database:	Environment Complete

Description
ISSN:	0264410X
DOI:	10.1016/j.vaccine.2018.05.110